# Oxford BioMedica (United Kingdom)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/oxford-biomedica-united-kingdom/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 54.5 |
| Citations | 1,178,471 |
| City | Oxford |
| Country | GB |
| Description | Oxford BioMedica (United Kingdom) is a research organisation in Oxford, GB. OpenAlex records 8,159 works and 1,178,471 citations for it. 1,587 researchers list it as their most recent affiliation. |
| Homepage | http://www.oxfordbiomedica.co.uk/ |
| OpenAlex ID | https://openalex.org/I4210146357 |
| Researchers | 1,587 |
| ROR ID | https://ror.org/03dp0vf82 |
| Type | company |
| Works | 8,159 |

## University papers

- [Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial](https://scholariq.org/papers/safety-and-immunogenicity-of-the-chadox1-ncov-19-vaccine-against-sars-cov-2-a/)
- [Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial](https://scholariq.org/papers/efficacy-and-safety-of-voretigene-neparvovec-aav2-hrpe65v2-in-patients-with/)
- [T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial](https://scholariq.org/papers/t-cell-and-antibody-responses-induced-by-a-single-dose-of-chadox1-ncov-19/)
- [Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses](https://scholariq.org/papers/phase-1-2-trial-of-sars-cov-2-vaccine-chadox1-ncov-19-with-a-booster-dose/)
- [Assessing the potential for AAV vector genotoxicity in a murine model](https://scholariq.org/papers/assessing-the-potential-for-aav-vector-genotoxicity-in-a-murine-model/)
- [Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 Vaccine](https://scholariq.org/papers/native-like-sars-cov-2-spike-glycoprotein-expressed-by-chadox1-ncov-19-azd1222/)

## University top topics

Showing 8 of 25.

- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Virus-based gene therapy research](https://scholariq.org/topics/virus-based-gene-therapy-research/)
- [Respiratory viral infections research](https://scholariq.org/topics/respiratory-viral-infections-research/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.